Log in

Antiproliferative Activity of a New Nitrosyl Iron Complex with Cysteamine in Human Tumor Cells In Vitro

  • Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied cytotoxic activity of a new NO-releasing tetranitrosyl binuclear iron complex with cysteamine (CysAm) for human tumor cells, the relationship between the expression of O6-methylguanine-DNA methyltransferase (MGMT) and cell sensitivity to CysAm, and apoptosis-inducing capacity of this preparation. It was found that histogenetically different cell lines are characterized by different sensitivity to CysAm, and this parameter correlated with the basal level of MGMT. CysAm induced apoptosis via activation of caspases 3 and 7. These data suggest that CysAm can be considered as a potential antitumor agent, but definitive conclusions can be made after preclinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zhukova OS. In vitro models in screening of different nature antitumor compounds. Ros. Bioter. Zh. 2004;3(3):12-18. Russian.

    Google Scholar 

  2. Lukashin VP, Grebenyuk AN. Comparative analysis of antiradiation effectiveness of different doses of cystamin, heparin, and naphtizin in experiments on mice. Radiats. Biol. Radioekol. 2001;41(3):310-312. Russian.

    CAS  Google Scholar 

  3. Treshchalina EM, Zhukova OS, Gerasimova GK, Andronova NV, Garin AM. Methodical recommendations on studying antitumor activity of pharmacological substances. Manual for Preclinical Studies of New Pharmacological Substances. Mironov AN, ed. Moscow, 2012. P. 642-656. Russian.

  4. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ Jr. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 2000;60(21):6101-6110.

    CAS  PubMed  Google Scholar 

  5. An SH, Kang JH, Kim DH, Lee MS. Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells. BMB Rep. 2011;44(3):211-216.

    Article  CAS  PubMed  Google Scholar 

  6. Harris RE, Beebe-Donk J, Doss H, Burr Doss D. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol. Rep. 2005;13(4):559-583.

    CAS  PubMed  Google Scholar 

  7. Isono S, Fujishima M, Azumi T, Hashimoto Y, Komoike Y, Yukawa M, Watatani M. O6-methylguanine-DNA methyltransferase as a prognostic and predictive marker for basal-like breast cancer treated with cyclophosphamide-based chemotherapy. Oncol. Lett. 2014;7(6):1778-1784.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Kielbik M, Klink M, Brzezinska M, Szulc I, Sulowska Z. Nitric oxide donors: spermine/NO and diethylenetriamine/NO induce ovarian cancer cell death and affect STAT3 and AKT signaling proteins. Nitric Oxide. 2013;35:93-109.

    Article  CAS  PubMed  Google Scholar 

  9. Lee BW, Olin MR, Johnson GL, Griffin RJ. In vitro and in vivo apoptosis detection using membrane permeant fluorescent-labeled inhibitors of caspases. Methods Mol. Biol. 2008;414:109-135.

    CAS  PubMed  Google Scholar 

  10. Liu L, Xu-Welliver M, Kanugula S, Pegg AE. Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Cancer Res. 2002;62(11):3037-3043.

    CAS  PubMed  Google Scholar 

  11. Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J. Biol. Chem. 2009;284(33):21,777-21,781.

    Article  CAS  Google Scholar 

  12. Sanina NA, Kozub GI, Emelyanova NS, Kondrateva TA, Korchagin DV, Shilov GV, Ovanesyan NS, Aldoshin SM, Zhukova OS. Synthesis, structure, NO donor activity of iron-sulfur nitrosyl complex with 2-aminophenol-2-yl and its antiproliferative activity against human cancer cells. J. Coord. Chem. 2013;66(20):3602-3618.

    Article  CAS  Google Scholar 

  13. Takimoto CH. Anticancer drug development at the US National Cancer Institute. Cancer Chemother. Pharmacol. 2003;52(Suppl. 1):S29-S33.

    Article  CAS  PubMed  Google Scholar 

  14. Tesei A, Zoli W, Fabbri F, Leonetti C, Rosetti M, Bolla M, Amadori D, Silvestrini R. NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells. Nitric Oxide. 2008;19(2):225-236.

    Article  CAS  PubMed  Google Scholar 

  15. Yamori T. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics. Cancer Chemother. Pharmacol. 2003;52(Suppl. 1):S74-S79.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. S. Zhukova.

Additional information

Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 4, pp. 275-280, October, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhukova, O.S., Smirnova, Z.S., Chikileva, I.O. et al. Antiproliferative Activity of a New Nitrosyl Iron Complex with Cysteamine in Human Tumor Cells In Vitro . Bull Exp Biol Med 162, 583–588 (2017). https://doi.org/10.1007/s10517-017-3663-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3663-8

Key Words

Navigation